1-10 of 10
De-Chao Yu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Conditionally replicating oncolytic adenovirus CG5757: Preferential infection in primary human tumor tissues and its potential for systemic application

Yuanhao Li, Trini Arroyo, Steve Thorne, Tony Reid, Natalie Nguyen, Neeraja Idamakanti, Melinda Vanroey, Gail Colbern, De-Chao Yu
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1252.
Published: 01 May 2005
View article titled, Conditionally replicating oncolytic adenovirus CG5757: Preferential infection in primary human tumor tissues and its potential for systemic application
Journal Articles

CG0070, a conditionally replicating GM-CSF armed oncolytic adenovirus for the treatment of bladder cancer

Nagarajan Ramesh, Ying Ge, Shanti Ganesh, Seshidhar Reddy Police, Peter Working, De-Chao Yu
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1185.
Published: 01 May 2005
View article titled, CG0070, a conditionally replicating GM-CSF armed oncolytic adenovirus for the treatment of bladder cancer
Journal Articles

Polycations enhance adenovirus mediated gene transfer and oncolysis of head and neck cancer and melanoma cells in vitro

Seshidhar Reddy Police, Lian Mo, Shanthi Ganesh, Yuanhao Li, Peter Working, De-Chao Yu
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 313.
Published: 01 May 2005
View article titled, Polycations enhance adenovirus mediated gene transfer and oncolysis of head and neck cancer and melanoma cells <em>in vitro</em>
Journal Articles

Oncolytic adenovirus CG5757 for the treatment of retinoblstoma (Rb) pathway-defective and telomerase-positive cancers.

Yuanhao Li, Orlena Tam, Natalie Nguyen, Melinda Vanroey, Gail Colbern, Trini Arroyo, Derek Ko, De-Chao Yu
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 540.
Published: 01 April 2004
View article titled, Oncolytic adenovirus CG5757 for the treatment of retinoblstoma (Rb) pathway-defective and telomerase-positive cancers.
Journal Articles

Identification of Human Uroplakin II Promoter and Its Use in the Construction of CG8840, a Urothelium-specific Adenovirus Variant That Eliminates Established Bladder Tumors in Combination with Docetaxel

Jane Zhang, Nagarajan Ramesh, Yu Chen, Yuanhao Li, Jeanette Dilley, Peter Working, De-Chao Yu
Journal: Cancer Research
Cancer Res (2002) 62 (13): 3743–3750.
Published: 01 July 2002
View article titled, Identification of Human Uroplakin II Promoter and Its Use in the Construction of CG8840, a Urothelium-specific Adenovirus Variant That Eliminates Established Bladder Tumors in Combination with Docetaxel
Open the PDF for Identification of Human Uroplakin II Promoter and Its Use in the Construction of CG8840, a Urothelium-specific Adenovirus Variant That Eliminates Established Bladder Tumors in Combination with Docetaxel in another window
Journal Articles

A Hepatocellular Carcinoma-specific Adenovirus Variant, CV890, Eliminates Distant Human Liver Tumors in Combination with Doxorubicin

Yuanhao Li, De-Chao Yu, Yu Chen, Pinky Amin, Hong Zhang, Natalie Nguyen, Daniel R. Henderson
Journal: Cancer Research
Cancer Res (2001) 61 (17): 6428–6436.
Published: 01 September 2001
View article titled, A Hepatocellular Carcinoma-specific Adenovirus Variant, CV890, Eliminates Distant Human Liver Tumors in Combination with Doxorubicin
Open the PDF for A Hepatocellular Carcinoma-specific Adenovirus Variant, CV890, Eliminates Distant Human Liver Tumors in Combination with Doxorubicin in another window
Journal Articles

CV706, a Prostate Cancer-specific Adenovirus Variant, in Combination with Radiotherapy Produces Synergistic Antitumor Efficacy without Increasing Toxicity

Yu Chen, Theodore DeWeese, Jeanette Dilley, Yiwei Zhang, Yuanhao Li, Nagarajan Ramesh, Jake Lee, Rukmini Pennathur-Das, John Radzyminski, Joseph Wypych, Dominic Brignetti, Sara Scott, Jennifer Stephens, David B. Karpf, Daniel R. Henderson, De-Chao Yu
Journal: Cancer Research
Cancer Res (2001) 61 (14): 5453–5460.
Published: 01 July 2001
View article titled, CV706, a Prostate Cancer-specific Adenovirus Variant, in Combination with Radiotherapy Produces Synergistic Antitumor Efficacy without Increasing Toxicity
Open the PDF for CV706, a Prostate Cancer-specific Adenovirus Variant, in Combination with Radiotherapy Produces Synergistic Antitumor Efficacy without Increasing Toxicity in another window
Journal Articles

Antitumor Synergy of CV787, a Prostate Cancer-specific Adenovirus, and Paclitaxel and Docetaxel

De-Chao Yu, Yu Chen, Jeanette Dilley, Yuanhao Li, Millicent Embry, Hong Zhang, Natalie Nguyen, Pinky Amin, Joe Oh, Daniel R. Henderson
Journal: Cancer Research
Cancer Res (2001) 61 (2): 517–525.
Published: 01 January 2001
View article titled, Antitumor Synergy of CV787, a Prostate Cancer-specific Adenovirus, and Paclitaxel and Docetaxel
Open the PDF for Antitumor Synergy of CV787, a Prostate Cancer-specific Adenovirus, and Paclitaxel and Docetaxel in another window
Journal Articles

The Addition of Adenovirus Type 5 Region E3 Enables Calydon Virus 787 to Eliminate Distant Prostate Tumor Xenografts

De-Chao Yu, Yu Chen, Monica Seng, Jeanette Dilley, Daniel R. Henderson
Journal: Cancer Research
Cancer Res (1999) 59 (17): 4200–4203.
Published: 01 September 1999
View article titled, The Addition of Adenovirus Type 5 Region E3 Enables Calydon Virus 787 to Eliminate Distant Prostate Tumor Xenografts
Open the PDF for The Addition of Adenovirus Type 5 Region E3 Enables Calydon Virus 787 to Eliminate Distant Prostate Tumor Xenografts in another window
Journal Articles

Identification of the Transcriptional Regulatory Sequences of Human Kallikrein 2 and Their Use in the Construction of Calydon Virus 764, an Attenuated Replication Competent Adenovirus for Prostate Cancer Therapy

De-Chao Yu, Gordon T. Sakamoto, Daniel R. Henderson
Journal: Cancer Research
Cancer Res (1999) 59 (7): 1498–1504.
Published: 01 April 1999
View article titled, Identification of the Transcriptional Regulatory Sequences of Human Kallikrein 2 and Their Use in the Construction of Calydon Virus 764, an Attenuated Replication Competent Adenovirus for Prostate Cancer Therapy
Open the PDF for Identification of the Transcriptional Regulatory Sequences of Human Kallikrein 2 and Their Use in the Construction of Calydon Virus 764, an Attenuated Replication Competent Adenovirus for Prostate Cancer Therapy in another window